Streetbeat News

Stock Prices

BTGOF

DIS

GOOG

HEINY

HNHPF

JBHT

NVO

PCRFY

WMT

YELL

Several significant business events have occurred. Alphabet Inc's Google has had an investigation into alleged abuse of dominance closed by the Italian Competition Authority. Toyota Motor Corp is strengthening its local development of intelligence and electrification technology in China. J.B. Hunt Transport Services is buying 13 zero-emission trucks from Nikola Corp. BT Group PLC has appointed Allison Kirkby as CEO. Walt Disney Co has appointed former executives Kevin Mayer and Tom Staggs as advisors to CEO Bob Iger. Foxconn is expanding in India with a $195M investment. Novo Nordisk A/S's weight-loss drug Wegovy has hit the German market. Walmart Inc has bought out Tiger Global's stake in Flipkart for $1.4B. Yellow Corporation has ceased operations. Panasonic Holdings Corp and Heineken NV have released their earnings reports.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 2:14 pm

YELL

Trading of Yellow Corporation's shares has resumed.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 2:11 pm

INVZ

Innoviz Technologies (INVZ) has seen a significant option alert for August 18 $3 calls. A total of 300 contracts were traded near the ask price at $1.1, compared to an open interest of 37,846. The reference price was $3.93.

Portfolio Pulse from Charles Gross

July 31, 2023 | 2:09 pm

IMGN

ImmunoGen Inc reported Q2 revenues of $83.15 million, surpassing the consensus of $42.84 million and higher than $14.16 million a year ago. The increase was primarily driven by Elahere net sales. The company reported a net loss of $(4.25) million, or $(0.02) per share, compared to a loss of $(62.02) million, or $(0.24) per share a year ago. ImmunoGen expects FY23 operating expenses of $350 million-$365 million, higher than the $320 million-$335 million expected earlier, on higher spending in support of Elahere.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 2:09 pm

CVX

Goldman Sachs has upgraded Chevron Corporation's stock from Neutral to Buy and set a price target of $187. This has led to an increase in Chevron's share trading.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 2:08 pm

DXCM

Barclays has maintained an Equal-Weight rating on DexCom's stock and increased its price target from $115 to $138. This has resulted in DexCom's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 2:07 pm

FSR

Fisker Inc. has announced that deliveries of its Fisker Ocean electric SUV have begun. The vehicle, which can be ordered online or through the Fisker App, boasts the longest EV range of any Electric SUV at 360 miles.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 2:04 pm

ALL

Allstate (NYSE:ALL) is set to release its latest quarterly earnings report on August 1, 2023. Analysts estimate an earnings per share (EPS) of $-3.83. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. However, the stock has been generally negative over the last 52-week period, with shares down 2.18%.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:04 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) is set to release its latest quarterly earnings report on Tuesday, 2023-08-01. Analysts estimate an earnings per share (EPS) of $0.77. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares were trading at $102.75 as of July 28, with a 52-week increase of 11.22%.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:04 pm

INCY

Incyte (NASDAQ:INCY) is set to release its quarterly earnings report on August 1, 2023. Analysts estimate an EPS of $0.88. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. Over the last 52-week period, Incyte's shares are down 12.16%.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:04 pm